LOSS OF BAP1 CONFERS RESISTANCE TO FERROPTOSIS AND PROMOTES CHOLANGIOCARCINOMA DEVELOPMENT

被引:0
|
作者
Classon, Peyton [1 ]
Jaramillo, Sophia [1 ]
Carlson, Danielle [1 ]
Yan, Irene [2 ]
Ilyas, Sumera [1 ]
Smoot, Rory [1 ]
Gores, Gregory [1 ]
Patel, Tushar
Povero, Davide [1 ]
机构
[1] Mayo Clin Rochester, Rochester, MN USA
[2] Mayo Clin Florida, Jacksonville, FL USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1830
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
    Andrici, Juliana
    Goeppert, Benjamin
    Sioson, Loretta
    Clarkson, Adele
    Renner, Marcus
    Stenzinger, Albrecht
    Tayao, Michael
    Watson, Nicole
    Farzin, Mahtab
    Toon, Christopher W.
    Smith, Ross C.
    Mittal, Anubhav
    Samra, Jaswinder S.
    Hugh, Thomas J.
    Chou, Angela
    Lawlor, Rita T.
    Weichert, Wilko
    Schirmacher, Peter
    Sperandio, Nicola
    Ruzzenente, Andrea
    Scarpa, Aldo
    Gill, Anthony J.
    MEDICINE, 2016, 95 (02)
  • [2] BAP1 Loss in Cholangiocarcinoma is Strongly Associated with Tumor Site
    Purushothaman, Sonya
    Lagana, Stephen
    Rubino, Anthony
    Remotti, Helen
    MODERN PATHOLOGY, 2018, 31 : 686 - 686
  • [3] BAP1 Loss in Cholangiocarcinoma is Strongly Associated with Tumor Site
    Purushothaman, Sonya
    Lagana, Stephen
    Rubino, Anthony
    Remotti, Helen
    LABORATORY INVESTIGATION, 2018, 98 : 686 - 686
  • [4] Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma
    Marcus, Rebecca
    Ferri-Borgogno, Sammy
    Hosein, Abdel
    Foo, Wai Chin
    Ghosh, Bidyut
    Zhao, Jun
    Rajapakshe, Kimal
    Brugarolas, James
    Maitra, Anirban
    Gupta, Sonal
    CANCERS, 2021, 13 (22)
  • [5] Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss
    Misumi, Kento
    Hayashi, Akimasa
    Shibahara, Junji
    Arita, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Fukayama, Masashi
    HISTOPATHOLOGY, 2017, 70 (05) : 766 - 774
  • [6] BAP1 deubiquitinates ACLY to promote lipogenesis yet predisposing cholangiocarcinoma to iron overload and ferroptosis
    Classon, Peyton
    Jaramillo, Sophia
    Carlson, Danielle
    Yan, Irene
    Patel, Tushar
    Ilyas, Sumera I.
    Smoot, Rory L.
    Gores, Gregory J.
    Povero, Davide
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Exploiting ferroptosis in mutant BAP1 uveal melanoma
    Cunanan, Camille J.
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations
    Mochel, Mark C.
    Pins, Adriano
    Nose, Vania
    Hoang, Mai P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (06) : 901 - 904
  • [9] BAP1 links metabolic regulation of ferroptosis to tumour suppression
    Zhang, Yilei
    Shi, Jiejun
    Liu, Xiaoguang
    Feng, Li
    Gong, Zihua
    Koppula, Pranavi
    Sirohi, Kapil
    Li, Xu
    Wei, Yongkun
    Lee, Hyemin
    Zhuang, Li
    Chen, Gang
    Xiao, Zhen-Dong
    Hung, Mien-Chie
    Chen, Junjie
    Huang, Peng
    Li, Wei
    Gan, Boyi
    NATURE CELL BIOLOGY, 2018, 20 (10) : 1181 - +
  • [10] BAP1 mutation-associated cholangiocarcinoma: An aggressive disease
    Anand, Deepa
    Churi, Chaitanya
    Rashid, Asif
    Shroff, Rachna T.
    Zuo, Mingxin
    Conrad, Claudius
    Vauthey, Jean-Nicolas
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)